Dipyridamole: an antioxidant that promotes the proliferation of aorta smooth muscle cells.

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Artery

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 6820629
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhanced prostacyclin production by dipyridamole in man

  2004cited by this paper
• Regulation of cell division in a human glioma cell clone by arachidonic acid and alpha-tocopherolquinone.

  1982cited by this paper
• Image analysis for the automated estimation of clonal growth and its application to the growth of smooth muscle cells

  1982cited by this paper
• George Lyman Duff Memorial Lecture. Atherosclerosis: a problem of the biology of arterial wall cells and their interactions with blood components.

  1981cited by this paper
• Polyunsaturated fatty acid accumulation in the lipids of cultured fibroblasts and smooth muscle cells.

  1981cited by this paper
• The effect of low-dose aspirin and dipyridamole upon atherosclerosis in the rabbit.

  1981cited by this paper
• Effect of polyunsaturated fatty acids and antioxidants on lipid peroxidation in tissue cultures.

  1981cited by this paper
• Serotonin receptor-mediated stimulation of bovine smooth muscle cell prostacyclin synthesis and its modulation by platelet-derived growth factor.

  1981cited by this paper
• Triglycerides, lipid droplets, and lysosomes in aorta smooth muscle cells during the control of cell proliferation with polyunsaturated fatty acids and vitamin E.

  1980cited by this paper
• DIPYRIDAMOLE: A POTENT STIMULATOR OF PROSTACYCLIN (PGI2) BIOSYNTHESIS

  1980cited by this paper
• Low density lipoproteins (LDL) are carriers for lipid peroxides and inhibit prostacyclin (PGI2) biosynthesis in arteries.

  1980cited by this paper
• Inactivation of vascular prostacyclin synthetase by platelet lipoxygenase products.

  1980cited by this paper
• Polyunsaturated fatty acids, vitamin E, and the proliferation of aortic smooth muscle cells.

  1979cited by this paper
• Effects of dipyridamole in experimental atherosclerosis. Action on PGI2, platelet aggregation and atherosclerotic plaque formation.

  1979cited by this paper
• Studies on the progression and regression of coronary and peripheral atherosclerosis in the cynomolgus monkey. I. Effects of dipyridamole and aspirin.

  1979cited by this paper
• Effects of dipyridamole in vivo on ATP and cAMP content in platelets and arterial walls and on atherosclerotic plaque formation

  1979cited by this paper
• Effect of low and high methional concentrations on prostaglandin biosynthesis in microsomes from bovine and sheep vesicular glands.

  1979cited by this paper
• Effect of dipyridamole on the survival of experimental critical skin flaps.

  1979cited by this paper
• Is human arterial smooth muscle cell proliferation regulated by prostacyclin?

  1979cited by this paper
• Proliferative activity of myocardial capillary wall cells in dipyridamole--treated rats.

  1978cited by this paper
• Fatty acids and their prostaglandin derivatives: inhibitors of proliferation in aortic smooth muscle cells.

  1977cited by this paper
• Differential inhibitory effects of vitamin E and other antioxidants on prostaglandin synthetase, platelet aggregation and lipoxidase.

  1977cited by this paper
• Malondialdehyde formation as an indicator of prostaglandin production by human platelets.

  1976cited by this paper
• Comparison of the reaction of cultured smooth and cardiac muscle cells and fibroblasts to specific antibodies to myosin

  1975cited by this paper
• A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro.

  1974cited by this paper
• Position of double bonds in the fatty acids of cholesterol esters from human aorta.

  1970cited by this paper

• Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients.

  2020cites this paper
• Chemotherapy-Associated Oxidative Stress: Impact on Chemotherapeutic Effectiveness

  2004cites this paper
• Antioxidant properties of dipyridamole as assessed by chemiluminescence.

  2003cites this paper
• Dietary Antioxidants During Cancer Chemotherapy: Impact on Chemotherapeutic Effectiveness and Development of Side Effects

  2000cites this paper
• Antioxidants and dipyridamole inhibit HIV-1 gp120-induced free radical-based oxidative damage to human monocytoid cells.

  1997cites this paper
• Modulation by Oxidants and Antioxidants of Signal Transduction and Smooth Muscle Cell Proliferation

  1997cites this paper
• 5 – Antioxidants in Biology

  1997cites this paper
• Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole

  1996cites this paper
• The role of hydrogen peroxide and RRR-alpha-tocopherol in smooth muscle cell proliferation.

  1996cites this paper
• Antioxidant and cytotoxic tocopheryl quinones in normal and cancer cells.

  1995cites this paper
• A potent chain-breaking antioxidant activity of the cardiovascular drug dipyridamole.

  1995cites this paper
• d-α-Tocopherol and Cell Proliferation

  1994cites this paper
• Pharmacology of smooth muscle cell replication.

  1992cites this paper
• Reaction of dipyridamole with the hydroxyl radical

  1992cites this paper
• Effects of aspirin, dipyridamole, and dibutyryl cyclic adenosine monophosphate on platelet-derived growth factor A chain mRNA levels in human saphenous vein endothelial cells and smooth muscle cells.

  1991cites this paper
• Multiple effects of dipyridamole on neutrophils and mononuclear leukocytes: adenosine-dependent and adenosine-independent mechanisms.

  1991cites this paper
• Paradoxical Effects of Vitamin E: Oxidized Lipoproteins, Prostanoids and the Pathogenesis of Atherosclerosis

  1990cites this paper
• Effects of oxidized low density lipoproteins on arachidonic acid metabolism in smooth muscle cells.

  1990cites this paper
• Gastric antiulcer and cytoprotective effects of dipyridamole in rats.

  1990cites this paper
• Superoxide Anion Scavenging Property of Dipyridamole

  1989cites this paper
• Dipyridamole inhibits lipid peroxidation and scavenges oxygen radicals

  1989cites this paper
• The initiation of membrane lipid peroxidation during bacteria-induced hypersensitive reaction

  1987cites this paper
• Failure of Antiplatelet Treatment in Dietary Atherosclerosis

  1987cites this paper
• Dipyridamole Inhibits Leukotriene B4 Synthesis

  1987cites this paper
• Failure of Antiplatelet Treatment in Dietary Atherosclerosis A Serial Intervention Study 46

  1987cites this paper
• Elevated Lipid Peroxidation in Rats Induced by Dietary Lipids and N-Nitrosodimethylamine and its Inhibition by Indomethacin Monitored Via Ethane Exhalation

  1987cites this paper
• The role of aspirin and dipyridamole on vascular DNA synthesis and intimal hyperplasia following deendothelialization.

  1986cites this paper
• Pharmacology of the interaction between platelets and vessel wall.

  1986cites this paper
• Metabolism of n-3 polyunsaturated fatty acids and modification of phospholipids in cultured rabbit aortic smooth muscle cells.

  1985cites this paper
• Role of prostanoids and lipid peroxides as mediators of the 12-O-tetradecanoylphorbol-13-acetate effect on cell growth

  1985cites this paper
• Fatty acid metabolism and cell proliferation. VII. Antioxidant effects of tocopherols and their quinones

  1985cites this paper
• Modification of two types of cholesterol atherosclerosis in rabbits by blocking lipoprotein lysine epsilon-amino groups.

  1985cites this paper
• Effect of Dipyridamole Plus Pentoxifylline in Patients with Diffuse Cerebrovascular Insufficiency

  1985cites this paper
• Prostacyclin production by rat aorta "in vitro" is increased by the combined action of dipyridamole plus pentoxifylline.

  1985cites this paper
• CHAPTER 4 – Fatty Acid Paradoxes in the Control of Cell Proliferation: Prostaglandins, Lipid Peroxides, and Cooxidation Reactions

  1984cites this paper
• Fatty acid metabolism and cell proliferation. V. Evaluation of pathways for the generation of lipid peroxides

  1984cites this paper
• Prolonging prostacyclin production by nafazatrom or dipyridamole.

  1984cites this paper
• Fatty acid metabolism and cell proliferation: IV. Effect of prostanoid biosynthesis from endogenous fatty acid release with cyclosporin-A

  1983cites this paper
• Fatty acid metabolism and cell proliferation. III. Effect of prostaglandin biosynthesis either from exogenous fatty acid or endogenous fatty acid release with hydralazine

  1983cites this paper